M. Patrick Stagg
Impact in
- Oncology top 10%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
- Co-authors
- Hugh Mulcahy (1 shared paper)Diarmuid P. O’Donoghue (1 shared paper)Mary Toner (1 shared paper)Michael Jeffers (1 shared paper)Robert B. Diasio (2 shared papers)Jean‐Pierre Sommadossi (1 shared paper)E M Cretton (1 shared paper)John D. Hainsworth (3 shared papers)
- Journals
- Blood (2 papers)Journal of Clinical Oncology (2 papers)The Journal of Pathology (1 paper)The American Journal of Medicine (1 paper)Cancer (1 paper)
- Partner nations
- United StatesNigeriaSouth Africa
In The Last Decade
M. Patrick Stagg
19 papers receiving 531 citations
Peers
Comparison fields: 5 of 56
- Oncology 228
- Virology 31
- Hematology 73
- Genetics 44
- Pulmonary and Respiratory Medicine 120
Countries citing papers authored by M. Patrick Stagg
This map shows the geographic impact of M. Patrick Stagg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Patrick Stagg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Patrick Stagg more than expected).
Fields of papers citing papers by M. Patrick Stagg
This network shows the impact of papers produced by M. Patrick Stagg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Patrick Stagg. The network helps show where M. Patrick Stagg may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Patrick Stagg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 214 | |
| 2 | 1992 | 88 | |
| 3 | A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trial. | 1994 | 57 |
| 4 | 1998 | 38 | |
| 5 | 2005 | 32 | |
| 6 | 1987 | 24 | |
| 7 | 2003 | 23 | |
| 8 | 1984 | 20 | |
| 9 | 1989 | 18 | |
| 10 | Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial). | 1995 | 10 |
| 11 | 2020 | 7 | |
| 12 | 2000 | 6 | |
| 13 | 2020 | 4 | |
| 14 | 2021 | 3 | |
| 15 | 2002 | 3 | |
| 16 | 2021 | 2 | |
| 17 | 1990 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2025 | 0 |
About M. Patrick Stagg
M. Patrick Stagg is a scholar working on Oncology, Genetics, Infectious Diseases, Surgery and Hematology, having authored 21 papers that have together received 553 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Research Studies (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Acute Myeloid Leukemia Research (2 papers), Hemoglobinopathies and Related Disorders (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Oncology (228 citations), Virology (31 citations), Hematology (73 citations), Genetics (44 citations) and Pulmonary and Respiratory Medicine (120 citations). M. Patrick Stagg has collaborated with scholars based in United States, Nigeria and South Africa. Frequent co-authors include Hugh Mulcahy, Diarmuid P. O’Donoghue, Mary Toner, Michael Jeffers, Robert B. Diasio, Jean‐Pierre Sommadossi, E M Cretton, John D. Hainsworth, Orlando J. Martelo and A. A. Bartolucci. Their work appears in journals such as Blood, Journal of Clinical Oncology, The Journal of Pathology, The American Journal of Medicine and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.